Fig. 3
From: The genomic landscape of Epstein-Barr virus-associated pulmonary lymphoepithelioma-like carcinoma
Altered pathways in pulmonary LELC. Alterations defined as somatic mutations, focal amplifications, and deletions affecting Cell cycle (a), JAK/STAT (b), and NF-kappa B (c) signaling pathways are shown. Alteration frequencies are expressed as a percentage of samples form discovery cohort and validation cohort. LELC, lymphoepithelioma-like carcinoma
